Company Future Medicine Co., Ltd.

A341170

KR7341170009

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-07-03 EDT			5-day change	1st Jan Change
2,770 ^KRW	+12.15%		+23.11%	-59.68%

2022	Future Medicine Co., Ltd. has withdrawn its IPO.	CI
2021	Future Medicine Co., Ltd. has filed an IPO.	CI

Future Medicine Co Ltd is a Korea-based company mainly engaged in the synthetic drug development business. The Company is engaged in the development and sale of anti-inflammatory and anti-fibrotic agents, targeted anticancer drugs, immune anticancer drugs, metabolic cancer drugs, autoimmune diseases and targeted anticancer drugs, antiviral and other products.

Managers	Title	Age	Since
Wan-Seok Jeong CEO	Chief Executive Officer	51	-
Nak-Shin Jeong CEO	Chief Executive Officer	63	-

Members of the board	Title	Age	Since
Sang-Guk Lee BRD	Director/Board Member	62	17-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,533,205	9,091,411 ( 86.31 %)	0	86.31 %

Name	Equities	%	Valuation
Wan-Seok Jeong 1.672 %	176,147	1.672 %	316 150 ₩

Future Medicine Co., Ltd.

54 Changeop-ro Sujeong-gu

13449, Seongnam-si

http://www.futuremedicine.co.kr

address Future Medicine Co., Ltd.(A341170)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
FUTURE MEDICINE CO., LTD.	-59.68%	16.55M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+23.70%	44.09B
OTSUKA HOLDINGS CO., LTD.	+30.04%	23.18B
SANDOZ GROUP AG	+24.02%	15.66B
CIPLA LIMITED	+18.81%	14.35B
ZYDUS LIFESCIENCES LIMITED	+64.98%	13.2B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.78%	6.45B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.00%	5.63B